|Datum nieuwsfeit: 28-04-2004|
|Zoek soortgelijke berichten|
10E 28 April 2004
Q1 2004 operating profit of EUR 110 million substantially higher than expected
Sales up 29% from Q1 2003, mainly because of contribution from DSM Nutritional Products and autonomous volume growth of 5%
Operating profit 21% higher than in Q1 2003; net profit up 8% from Q1 2003
Development of DSM Nutritional Products above expectations
DSM Anti-Infectives puts results of Life Science Products under strong pressure
Q2 operating profit expected to be around Q1 2004 level; profit on ordinary activities after taxation for 2004 expected to be clearly higher ...
Gratis persberichten ontvangen?
Profiteer van het gratis Nieuwsbank persberichtenfilter